Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma
This study is currently recruiting participants.
Verified April 2013 by Fred Hutchinson Cancer Research Center
Study NCT01110135
Information provided by Fred Hutchinson Cancer Research Center
First Received on April 20, 2010.
Last Updated on April 5, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
